Home › Biotheranostics Settles False Claims Allegations With DOJ for $2M

Biotheranostics Settles False Claims Allegations With DOJ for $2M

Apr 20, 2018

NEW YORK (GenomeWeb) – The US Department of Justice said on Thursday that Biotheranostics has agreed to pay $2 million to settle allegations that the company improperly billed Medicare for molecular breast cancer tests. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Aug
27
Featured Webinar

Case Study: Genetic Testing Lab Sees 25-Fold Scaleup with New Informatics System

Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

What's Popular?

In Cancer

  1. China FDA Approves Novogene CDx Test for NSCLC Therapies

  2. Natera Partners With Fox Chase to Evaluate ctDNA Cancer Assay

  3. Genetic Technologies Announces Planned Chinese Joint Venture

  4. MDxHealth Hopes to Build Lead in Prostate Risk Testing With Utility Evidence for SelectMDx

    Premium

  5. Dx Companies See Rise in Demand for Integrated Clinical Chemistry, Immunoassay Systems for Central Labs

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.